Chengyong Lei

No.1838 North Of Guangzhou Avenue
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

SFMBT2 hypermethylation promotes colorectal cancer progression and is a potential noninvasive biomarker for advanced CRC.

SFMBT2 hypermethylation promotes colorectal cancer progression and is a potential noninvasive biomarker for advanced CRC.

Journal: iScience

Published: July 12, 2025

Correlations of immune cell infiltration characteristics with clinicopathological parameters in patients with clear cell renal cell carcinoma

Correlations of immune cell infiltration characteristics with clinicopathological parameters in patients with clear cell renal cell carcinoma

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: June 27, 2025

Combining the DNA methylation markers of circulating tumor cells with immune infiltrating cells to assess recurrence and prognosis and to suggest a therapeutic strategy in stage III-IV colorectal cancer.

Combining the DNA methylation markers of circulating tumor cells with immune infiltrating cells to assess recurrence and prognosis and to suggest a therapeutic strategy in stage III-IV colorectal cancer.

Journal: Frontiers in immunology

Published: April 07, 2025

Case Report: Malignant peripheral nerve sheath tumor of the kidney with a novel granular cell morphology.

Case Report: Malignant peripheral nerve sheath tumor of the kidney with a novel granular cell morphology.

Journal: Frontiers in oncology

Published: January 13, 2025

Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.

Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.

Journal: The Journal of pathology

Published: June 18, 2022

Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer.

Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer.

Journal: Frontiers in oncology

Published: December 02, 2021

PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.

PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.

Journal: BMC cancer

Published: August 22, 2018

Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein.

Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein.

Journal: DNA and cell biology

Published: June 15, 2018

Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4.

Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4.

Journal: Oncogene

Published: May 26, 2017

HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways.

HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways.

Journal: Oncotarget

Published: August 05, 2016

Red and processed meat intake and risk of bladder cancer: a meta-analysis.

Red and processed meat intake and risk of bladder cancer: a meta-analysis.

Journal: International journal of clinical and experimental medicine

Published: June 11, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026